Frontiers in Pharmacology (Jan 2022)

Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells

  • Fedor Simko,
  • Fedor Simko,
  • Fedor Simko,
  • Tomas Baka

DOI
https://doi.org/10.3389/fphar.2022.842512
Journal volume & issue
Vol. 13

Abstract

Read online

No abstracts available.

Keywords